Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy.

Ramos, Hugo; Bogdanov, Patricia; Huerta, Jordi; Deàs-Just, Anna; Hernández, Cristina; Simó, Rafael

Ramos, Hugo; Bogdanov, Patricia; Huerta, Jordi; Deàs-Just, Anna; Hernández, Cristina; Simó, Rafael.

Afiliación

Ramos H; Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.
Bogdanov P; Center for Networked Biomedical Research of Diabetes and Associated Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ICSIII), 28029 Madrid, Spain.
Huerta J; Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.
Deàs-Just A; Center for Networked Biomedical Research of Diabetes and Associated Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ICSIII), 28029 Madrid, Spain.
Hernández C; Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.
Simó R; Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.

Antioxidants (Basel) ; 11(7)2022 Jul 21.

Article en En | MEDLINE | ID: mdl-35883908

Palabras clave

DPP-4 inhibitors; NRF2; antioxidant; diabetes; diabetic retinopathy; dipeptidyl peptidase-4; oxidative stress; sitagliptin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Antioxidants (Basel) Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google